Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US Courts Reject Reinstating FDA's Homeopathic Drug Policy As Challenge To Change Proceeds

Jun 09 2021

• By Malcolm Spicer

Related Content

US FDA Moves Homeopathic Drug Enforcement To Risk-Based Approach

Dec 19 2017

OTC Homeopathic Labels Must Include Scientific Disclaimers – FTC

Nov 16 2016

OTC Homeopathic Market Could Shrink Under US FDA Risk-Based Oversight, Trade Groups Say

Jun 28 2018

OTC Homeopathy Group Revises Label Disclaimers In Light Of FTC Scrutiny

Jun 28 2018

Additional Topics

International United States FDA Legal Issues Guidance Documents Advertising, Marketing & Sales Commercial Companies Compliance Enforcement Ingredients Manufacturing OTC Drugs Policy Regulation Consumer

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.